Tsalapati Konstantina, Vardavas Constantine I, Athanasakis Konstantinos, Thireos Eleftherios, Vozikis Athanassios, Pavi Elpida, Behrakis Panagiotis, Kyriopoulos Ioannis
1 Department of Health Economics, National School of Public Health, Athens, Greece.
2 Center for Global Tobacco Control, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA3 Smoking and Lung Cancer Research Center, Hellenic Cancer Society, Athens, Greece4 Biomedical Research Foundation of the Academy of Athens, Athens, Greece
Eur J Public Health. 2014 Jun;24(3):477-9. doi: 10.1093/eurpub/cku040. Epub 2014 Mar 27.
Our aim was to calculate the morbidity, hospitalizations and subsequent hospital costs for the treatment of the smoking-attributable fraction of diseases in Greece using a prevalence-based annual cost approach. In 2011, smoking accounted for 199,028 hospital admissions (8.9% of the national total), with attributable hospital treatment costs calculated at more than €554 million, which represents 10.7% of the national hospital budget. These results pose a compelling reason for the European Union to champion tobacco control as a means of reducing the financial and social burden of disease in Greece and other countries currently facing a financial maelstrom.
我们的目标是采用基于患病率的年度成本方法，计算希腊因吸烟导致的疾病部分的发病率、住院率及后续住院费用。2011年，吸烟导致199,028例住院（占全国总数的8.9%），可归因的住院治疗费用计算超过5.54亿欧元，占国家医院预算的10.7%。这些结果为欧盟倡导烟草控制提供了一个令人信服的理由，作为减轻希腊及其他目前正面临金融风暴的国家疾病的财政和社会负担的一种手段。
